Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Idioma
Intervalo de año de publicación
1.
Antibiot Khimioter ; 59(9-10): 38-43, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25975115

RESUMEN

The data on the resistance frequency of the diarrheagenic E. coli isolates to antibacterial agents and a specific bacteriophage are presented. The strains were isolated from hospitalized children in St. Petersburg in 2011-2013 and belonged to three groups, i.e. enteropathogenic (EPE), enterotoxigenic (ETE) and enteroinvasine (EIE). It was shown that in the children aged from 1 month to 18 years the average antibiotic resistance was maximum in the EIE isolates and decreased in the following order: EIE (15.2%), EPE (6.0%), ETE (3.3%). The clinical EIE isolates showed no resistance to the new generation cephalosporins (cefuroxime, cephepime) and nitrofurans. The E. coli isolates of the three groups were characterized by high resistance to a specific bacteriophage which decreased in the following order: ETE (44.8%), EIE (37.0%), EPE (28.8%). The multiple resistance of the diarrheagenic E. coli isolates of the three groups to the antibacterials averaged 2.8%. The maximum frequency of resistance of the clinical isolates of the three groups to nalidixic acid was observed: EIE - 28.6%, EPE - 26.3%, ETE - 9.1%. The results of the study may be useful in the tactics of therapy of diarrheagenic E. coli infection in children.


Asunto(s)
Antibacterianos/farmacología , Colifagos/fisiología , Escherichia coli Enteropatógena/efectos de los fármacos , Escherichia coli Enterotoxigénica/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Adolescente , Aminoglicósidos/farmacología , Cefalosporinas/farmacología , Niño , Preescolar , Cloranfenicol/farmacología , Farmacorresistencia Bacteriana , Escherichia coli Enteropatógena/crecimiento & desarrollo , Escherichia coli Enteropatógena/virología , Escherichia coli Enterotoxigénica/crecimiento & desarrollo , Escherichia coli Enterotoxigénica/virología , Escherichia coli/crecimiento & desarrollo , Escherichia coli/virología , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/microbiología , Femenino , Hospitalización , Humanos , Lactante , Masculino , Pruebas de Sensibilidad Microbiana , Nitrofuranos/farmacología , Federación de Rusia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA